1-6 of 6
Pierre Vera
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Combined Genotype Analysis of Tumor and Cell-Free DNA By Ultra-Deep Targeted Sequencing: Correlation with PET-Scan Imaging in a Prospective Cohort of Diffuse Large B-Cell Lymphoma Patients

Elodie Bohers, PhD, Pierre-Julien Viailly, Philippe Bertrand, Stephanie Becker, MD, Philippe Ruminy, PhD, Pascaline Etancelin, PharmD, Catherine Maingonnat, Jean-Michel Picquenot, MD, Anne Lise Menard, MD, Emilie Lemasle, MD, Nathalie Contentin, MD, Stéphane Leprêtre, MD, Pascal Lenain, MD, Aspasia Stamatoullas, MD, Helene Lanic, MD, Julie Libraire, Sandrine Vaudaux, Louis-Ferdinand Pepin, MD, Pierre Vera, Herve Tilly, Fabrice Jardin
Journal: Blood
Blood (2017) 130 (Supplement 1): 309.
https://doi.org/10.1182/blood.V130.Suppl_1.309.309
Published: 2017
Journal Articles

Molecular Profile and FDG-PET/CT Metabolic Tumor Volume Improve Risk Classification at Diagnosis for Patients with Diffuse Large B Cell Lymphoma

Anne-Ségolène Cottereau, MD, Hélène Lanic, MD, Michel Meignan, MD PhD, Pierre Vera, MD PhD, Hervé Tilly, MD PhD, Fabrice Jardin, MD PhD, Stéphanie Becker, MD PhD
Journal: Blood
Blood (2015) 126 (23): 1452.
https://doi.org/10.1182/blood.V126.23.1452.1452
Published: 2015
Journal Articles

SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma

Clinical Trials & Observations
René-Olivier Casasnovas, Michel Meignan, Alina Berriolo-Riedinger, Stéphane Bardet, Anne Julian, Catherine Thieblemont, Pierre Vera, Serge Bologna, Josette Brière, Jean-Philippe Jais, Corinne Haioun, Bertrand Coiffier, Franck Morschhauser
Journal: Blood
Blood (2011) 118 (1): 37–43.
https://doi.org/10.1182/blood-2010-12-327767
Published: 2011
Journal Articles

Interim [18F]Fluorodeoxyglucose Positron Emission Tomography SUVmax Reduction Is Superior to Visual Analysis to Predict Early patient's Outcome In Diffuse Large B-Cell Lymphoma

Rene-Olivier Casasnovas, MD, Michel Meignan, MD, Alina Berriolo-Riedinger, MD, Stephane Bardet, MD, Anne Julian, MD, Catherine Thieblemont, MD, Pierre Vera, MD, Serge Bologna, MD, Josette Briere, MD, Jean-Philippe Jais, MD, Corinne Haoiun, MD, Bertrand Coiffier, MD, PhD, Franck Morschhauser, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 320.
https://doi.org/10.1182/blood.V116.21.320.320
Published: 2010
Journal Articles

Early 18 fluorodeoxyglucose PET Scan as a Prognostic Tool in Diffuse Large B-Cell Lymphoma Patients Treated with An Anthracycline-Based Chemotherapy Plus Rituximab.

Violaine Safar, Jehan Dupuis, Fabrice Jardin, Christophe Fruchart, Stéphane Bardet, Pierre Vera, Herve Tilly, Michel Meignan, Emmanuel Itti, Corinne Haioun
Journal: Blood
Blood (2009) 114 (22): 98.
https://doi.org/10.1182/blood.V114.22.98.98
Published: 2009
Journal Articles

Patient-Specific Three Dimensional (3D) Dosimetry for 90 Y Ibritumomab Tiutexan (Zevalin®) in Patients with Follicular Lymphoma.

Karine Assié, PhD, Arnaud Dieudonné, PhD, Isabelle Gardin, PhD, Irène Buvat, PhD, Hervé Tilly, MD, Pierre Vera, MD
Journal: Blood
Blood (2005) 106 (11): 4780.
https://doi.org/10.1182/blood.V106.11.4780.4780
Published: 2005